The response to controlled ovarian stimulation in IVF treatment is one of the key components of treatment planning. In some patients, the ovaries responding to medication more limitedly than expected can be defined as "poor ovarian response." However, this situation alone does not allow for a definitive assessment of the probability of pregnancy.
In current reproductive medicine, a personalized treatment plan is created by evaluating ovarian reserve, patient age, previous treatment history, and clinical findings together. Therefore, poor ovarian response should be interpreted not only based on the number of oocytes obtained but by considering all clinical characteristics of the patient.
How Is Poor Ovarian Response Evaluated?
Poor ovarian response is a clinical condition associated with the development of fewer follicles than expected or the retrieval of a limited number of oocytes during controlled ovarian stimulation. However, the treatment process of two patients with the same number of oocytes may be evaluated differently.
For this reason, not only the oocyte count but also ovarian reserve, age, hormonal assessments, and previous stimulation response are considered together. Today, internationally accepted approaches such as the Bologna Criteria and the POSEIDON classification help in a more objective evaluation of poor ovarian response.
Based on Which Data Is the Treatment Plan Created?
Evaluation of Ovarian Reserve
In treatment planning, ovarian reserve is one of the most important clinical indicators. Anti-Müllerian Hormone (AMH) levels and antral follicle count (AFC) are commonly used parameters in evaluating ovarian reserve. However, these tests are not considered as measurements that predict the treatment outcome on their own.
Laboratory findings must be interpreted together with the patient's age, ultrasonographic evaluation, and clinical history.
Age and Oocyte Quality
Female age is an independent clinical variable that can affect not only ovarian reserve but also oocyte quality and the chromosomal structure of the embryo. Therefore, treatment planning may differ in two patients with similar AMH levels.
Previous Treatment Response
In patients who have previously undergone controlled ovarian stimulation, the follicle development achieved, the medication protocol used, and the oocyte count are among the clinical data that contribute to the planning of subsequent cycles. This approach helps to shape the treatment according to individual characteristics.
Why Is a Personalized Approach Adopted?
Poor ovarian response is not a condition that can be explained by a single laboratory result. Current international guidelines recommend that treatment planning be done by evaluating ovarian reserve, age, cause of infertility, previous treatment history, and data regarding embryo development together.
Therefore, different clinical approaches may be adopted for patients with the same AMH level or similar oocyte counts. The goal of treatment planning is to evaluate all clinical data belonging to the patient holistically.
Frequently Asked Questions (FAQ)
Are poor ovarian response and low ovarian reserve the same thing?
No. Low ovarian reserve is a clinical assessment indicating the biological capacity of the ovary. Poor ovarian response refers to the treatment response observed during controlled ovarian stimulation. These two concepts do not always carry the same meaning.
Does the AMH value alone determine the treatment plan?
No. AMH is an important biomarker providing information about ovarian reserve. However, treatment planning is not based solely on the AMH result; it is evaluated together with age, antral follicle count, and other clinical data.
Is every poor ovarian response evaluated in the same way?
No. The clinical approach is individualized by evaluating the patient's age, infertility history, previous treatment response, and findings regarding ovarian reserve together.
Does low ovarian reserve mean that pregnancy cannot be achieved?
No. Ovarian reserve is one of the parameters considered in treatment planning. It does not allow for a definitive assessment of the probability of pregnancy on its own.
For detailed information about the evaluation of poor ovarian response in IVF treatment and the clinical parameters considered in treatment planning, you can consult with the obstetrics and gynecology specialists at Private HRS Ankara Women's Hospital.
Disclaimer: The content on this page is for informational purposes only. Please consult your physician for diagnosis and treatment.
